Gene Therapy For Rare Disease Market Size And Share

  • Report Code : TIPRE00003413
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

تحليل حصة وحجم سوق العلاج الجيني للأمراض النادرة بحلول عام 2031

Buy Now

Gene Therapy For Rare Disease Market Report Gene Therapy For Rare Disease Market Scope and Analysis Gene Therapy For Rare Disease Market Size and Share

Gene Therapy For Rare Disease Market Report Analysis

Gene Therapy For Rare Disease Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BioMarin
  • Orchard Therapeutics plc.
  • Spark Therapeutics, Inc.
  • PTC Therapeutics
  • bluebird bio, Inc.
  • Kite Pharma
  • uniQure N.V.
  • Juno Therapeutics Inc. (Celgene Corporation)
  • Novartis AG

Regional Overview

  • أمريكا الشمالية
  • أوروبا
  • آسيا والمحيط الهادئ
  • أمريكا الجنوبية والوسطى
  • الشرق الأوسط وأفريقيا

Market Segmentation

By التطبيق العلاجي
  • الأورام
  • الاضطرابات العصبية
  • أمراض العيون
  • أمراض الدم
  • اضطرابات نقص المناعة
  • الاضطرابات الأيضية
  • أخرى